Role of Neurokinin 3 Receptors in Supraoptic Vasopressin and Oxytocin Neurons
Authors:
- Suwit J. SomponpunSSSuwit J. Somponpun
- Celia D. SladekCSCelia D. Sladek
Open Access
- 10 November 2004
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 24 (45) , 10103-10110
Abstract
Neurokinin 3 receptors (NK3-Rs) are expressed in the supraoptic nucleus (SON), and SON is innervated by substance P (SP)-expressing A1 neurons in the medulla. Because SP stimulates vasopressin (VP) and oxytocin release from explants of the hypothalamo-neurohypophyseal system (HNS), two hypotheses were tested: (1) SP-stimulated VP release is mediated by NK3-Rs, and (2) stimulation of the A1 pathway by hypotension activates SON NK3-Rs. Senktide, an NK3-R agonist, stimulated VP release from HNS explants, but neither a neurokinin 1 receptor antagonist [L732,138 (N-acetyl-L-tryptophan 3,5-bis(tri-fluoromethyl)benzyl ester)] nor two NK3-R antagonists (SB222200andSB235375) prevented SP-stimulated VP release. Because the affinity of these antagonists for rat NK-Rs may limit their efficacy, NK3-R internalization was used to assess the ability of SP to activate SON NK3-Rs. Senktide, SP, or vehicle was microinjected above SON. The brain was perfused 5 min after injection and stained for NK3-R immunoreactivity. Using confocal microscopy, the number of NK3-R-immunoreactive (-IR) endosomes was counted in a 5.62μ region of cytoplasm in SON neurons. Senktide, but not SP or vehicle, significantly increased the number of NK3-R-IR endosomes in the cytoplasm. When hypotension was induced with hydralazine, NK3-R internalization was observed within 5 min (p< 0.005). A decrease in cytoplasmic NK3-R immunoreactivity was observed within 15 min of hypotension. Unexpectedly, both senktide and hypotension resulted in translocation of NK3-R-IR immunoreactivity to the nucleus. Thus, although these studies do not identify SP as the NK3-R ligand, they do provide evidence for hypotension-induced release of an endogenous tachykinin in SON and evidence suggesting a role for NK3-Rs in transcription regulation.Keywords
This publication has 51 references indexed in Scilit:
- Central neurokinin 3 receptors increase systemic oxytocin release: interaction with norepinephrineExperimental Neurology, 2003
- Intracerebroventricular injection of senktide-induced Fos expression in vasopressin-containing hypothalamic neurons in the ratBrain Research, 2000
- In situ hybridization analysis of the distribution of neurokinin-3 mRNA in the rat central nervous systemJournal of Comparative Neurology, 1996
- Localization of the neuromedin K receptor (NK3) in the central nervous system of the ratJournal of Comparative Neurology, 1996
- Localization of neurokinin B in the central nervous system of the ratPeptides, 1992
- Molecular characterisation, expression and localisation of human neurokinin‐3 receptorFEBS Letters, 1992
- Reflex control of magnocellular vasopressin and oxytocin secretionTrends in Neurosciences, 1991
- Molecular cloning, structural characterization and functional expression of the human substance P receptorBiochemical and Biophysical Research Communications, 1991
- Osmotic control of vasopressin releaseTrends in Neurosciences, 1985
- Immunoreactive substance p in the tubero-hypophyseal system of the rat: Selective decrease in the neural lobe after dehydration and sodium loadingNeuroscience Letters, 1984